Placebo controlled trial of atomoxetine for treatment of ADHD in marijuana dependent patients.

Trial Profile

Placebo controlled trial of atomoxetine for treatment of ADHD in marijuana dependent patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2012

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder; Substance-related disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2012 Actual patient number is 38 according to ClinicalTrials.gov.
    • 06 Apr 2012 Actual patient number is 38 according to ClinicalTrials.gov.
    • 06 Apr 2012 Actual initiation date changed from Sep 2005 to Nov 2005 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top